CardioSignal offers a digital cardiac biomarker for self-monitoring, remote care, and point-of-care diagnostics. CardioSignal's patented technology enables a digital cardiac biomarker for several major heart diseases, representing a breakthrough in the fight against heart disease, the world's most expensive and lethal disease.CardioSignal's digital cardiac biomarkers can replace invasive and expensive standard care technologies, allowing for faster and less expensive care.

Apps

Health Care

Biotechnology

CardioSignal

CardioSignal's headquarters in Turku, Finland

The Palo Alto office focuses on regulatory compliance and strategic oversight in the biotechnology and life sciences sectors.

People (14)

Jobs (0)

Other offices